Stay updated on Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site’s footer revision indicator changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:26:31.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:17:25.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The study page now returns a 403 Forbidden error, indicating restricted access, instead of displaying the study record content.
    Difference
    18%
    Check dated 2026-09-19T14:11:29.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    A new page revision v3.6.6 was added and the previous revision v3.6.5 was removed, indicating a small update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-08-29T14:09:05.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, signaling a newer version of the page rather than changes to study details.
    Difference
    0.1%
    Check dated 2026-08-08T12:31:06.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Updated the page revision label from v3.6.3 to v3.6.4, signaling a minor metadata update to the page. This change does not alter study details, eligibility, endpoints, or results.
    Difference
    0.1%
    Check dated 2026-07-25T13:27:14.000Z thumbnail image

Stay in the know with updates to Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.